{"name":"Xiaofan Zhu","slug":"xiaofan-zhu","ticker":"","exchange":"","domain":"","description":"Xiaofan Zhu is a pharmaceutical company with a focus on developing and marketing specialty drugs. The company has two marketed products, including a combination of cyclophosphamide and cyclosporine A, as well as DNR. Limited financial and operational data is available.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"DNR:","genericName":"DNR:","slug":"dnr","indication":"Other","status":"marketed"},{"name":"cyclophosphamide,cyclosporine A","genericName":"cyclophosphamide,cyclosporine A","slug":"cyclophosphamide-cyclosporine-a","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"DNR:","genericName":"DNR:","slug":"dnr","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"cyclophosphamide,cyclosporine A","genericName":"cyclophosphamide,cyclosporine A","slug":"cyclophosphamide-cyclosporine-a","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE41RkIxUjlwNUlJU21RMnJIZmFFU0pwNm9YTHV0eVFKSURHU2Q5SUhMRl9ncmJpM3V1eHBCT0QwaXA5dXBfTXZsM3hQYXIzUVhoZ3pQZzRMRWgtREdZeS03QnhsTEZRZ0Q4NGc?oc=5","date":"2024-03-06","type":"pipeline","source":"Wiley Online Library","summary":"MOVICShiny: An interactive website for multi-omics integration and visualisation in cancer subtyping - Wiley Online Library","headline":"MOVICShiny: An interactive website for multi-omics integration and visualisation in cancer subtyping","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}